Price Chart

Profile

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
URL https://www.scpharmaceuticals.com
Investor Relations URL N/A
HQ State/Province Massachusetts
Sector Health Care
Industry Pharmaceuticals
Equity Style Small Cap/Value
Next Earnings Release Mar. 13, 2025 (est.)
Last Earnings Release Nov. 13, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
URL https://www.scpharmaceuticals.com
Investor Relations URL N/A
HQ State/Province Massachusetts
Sector Health Care
Industry Pharmaceuticals
Equity Style Small Cap/Value
Next Earnings Release Mar. 13, 2025 (est.)
Last Earnings Release Nov. 13, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A